Cochrane conclusions
•
In advanced stage metastatic uterine carcinosarcoma as
well as recurrent disease, adjuvant combination
chemotherapy with ifosfamide should be considered.
•
Combination chemotherapy with ifosfamide and paclitaxel
is associated with lower risk of death compared with
ifosfamide alone.
•
In addition, radiotherapy to the abdomen is not associated
with improved survival.
Cochrane Database of Systematic Reviews 2013